Which catheter works best for blood draws? new study has answers
NCT ID NCT06014099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two types of catheters (long peripheral and midline) for drawing blood in 162 hospitalized patients with difficult veins. The goal was to see which catheter improves first-stick success and reduces complications. Results could guide nurses in choosing the best tool for blood collection.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help nurses choose the best catheter for blood draws, improving success rates and patient comfort.
- What could go wrong
- This is a small, completed study focused on technique, not a new treatment. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
162 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Meet the international diagnostic criteria for metabolic syndrome (such as ATP III criteria or domestic Diabetes Branch of Chinese Medical Association criteria). * The estimated treatment time of intravenous infusion is 1-4 weeks, and the nature of the infusion drug meets the indications of LPCs and MCs. * Blood samples should be collected more than 3 times during the hospital. Exclusion Criteria: * A history of radiotherapy, thrombosis, and trauma at the catheter site. * Plan to discharge from the hospital with the tube. * Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterate, etc.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Catheter complications are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Linfang Zhao
Hangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple hand exercises may slash risk of painful IV complication
- Do arm catheters pose hidden risks in the ICU?
- New bandage for IVs could slash infection risk
- Spinal cord injury study reveals body's hidden stress during routine catheterization
- Tiny filters, big hope: new study aims to shield newborns from IV dangers
- Dialysis patients may get safer caps to fight deadly infections